Polymorphisms in melatonin synthesis pathways: Possible influences on depression

Journal of Circadian Rhythms

Volumn 9, Issue , 2011, Pages

  Kripke, Daniel F ^a,b   Nievergelt, Caroline M ^a   Tranah, Greg J ^c   Murray, Sarah S ^d   McCarthy, Michael J ^a,e   Rex, Katharine M ^a   Parimi, Neeta ^c   Kelsoe, John R ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS CLINIC   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d Scripps Genomic Medicine   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

AANAT; ASMT; Bipolar disorder; Depression; Lithium; Melatonin; N acetylserotonin; Serotonin

Indexed keywords

ACETYLSEROTONIN METHYLTRANSFERASE; ARALKYLAMINE ACETYLTRANSFERASE; LITHIUM; MELATONIN;

ADULT; AGED; ALLELE; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CONTROLLED STUDY; DELAYED SLEEP PHASE DISORDER; DEPRESSION; FEMALE; GENETIC ANALYSIS; GENOTYPE; HORMONE SYNTHESIS; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP APNEA SYNDROME; SLEEP DISORDER;

EID: 79961130282     PISSN: None     EISSN: 17403391     Source Type: Journal    
DOI: 10.1186/1740-3391-9-8     Document Type: Article

References (43)

1. Beck-Friis J, Kjellman BF, Aperia B, Unden F, von Rosen D, Ljunggren JG, Wetterberg L. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatrica Scandinavica 1985, 71:319-330. 10.1111/j.1600-0447.1985.tb02531.x, 4039876.
2. Parry BL, Mostofi N, Klauber MR, Resnick A. Plasma melatonin circadian rhythms during the menstrual cycle and after light therapy in premenstrual dysphoric disorder and normal control subjects. J Biol Rhythms 1997, 12:47-4. 10.1177/074873049701200107, 9104690.
3. Tuunainen A, Kripke DF, Elliott JA, Assmus JD, Rex KM, Klauber MR, Langer RD. Depression and endogenous melatonin in postmenopausal women. J Affect Dis 2002, 69:149-158. 10.1016/S0165-0327(01)00303-2, 12103461.
4. Kripke DF, Youngstedt SD, Rex KM, Klauber MR, Elliott JA. Melatonin excretion with affect disorders over age 60. Psychiatry Res 2003, 118:47-54. 10.1016/S0165-1781(03)00060-X, 12759161.
5. Terman JS, Terman M, Lo ES, Cooper TB. Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry 2001, 58:69-75. 10.1001/archpsyc.58.1.69, 11146760.
6. Emens J, Lewy A, Kinzie JM, Arntz D, Rough J. Circadian misalignment in major depressive disorder. Psychiatry Res 2009, 168:259-261. 10.1016/j.psychres.2009.04.009, 19524304.
7. Lewy AJ. Circadian misalignment in mood disturbances. Curr Psychiatry Rep 2009, 11:459-465. 10.1007/s11920-009-0070-5, 19909668.
8. Dardente H, Wyse CA, Birnie MJ, Dupre SM, Loudon AS, Lincoln GA, Hazlerigg DG. A molecular switch for photoperiod responsiveness in mammals. Curr Biol 2010, 20:2193-2198. 10.1016/j.cub.2010.10.048, 21129971.
9. Kripke DF, Rex KM, Ancoli-Israel S, Nievergelt CM, Klimecki W, Kelsoe JR. Delayed sleep phase cases and controls. J Circadian Rhythms 2008, 6:1. 10.1186/1740-3391-6-1, 2391143, 18445295.
10. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000, 157:1552-1562. 10.1176/appi.ajp.157.10.1552, 11007705.
11. Ioannidis JP. Why most published research findings are false. PLoS Med 2005, 2:e124. 10.1371/journal.pmed.0020124, 1182327, 16060722.
12. Galecki P, Szemraj J, Bartosz G, Bienkiewicz M, Galecka E, Florkowski A, Lewinski A, Karbownik-Lewinska M. Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder. J Pineal Res 2010, 48:311-317. 10.1111/j.1600-079X.2010.00754.x, 20433639.
13. Melke J, Goubran BH, Chaste P, Betancur C, Nygren G, Anckarsater H, Rastam M, Stahlberg O, Gillberg IC, Delorme R, Chabane N, Mouren-Simeoni MC, Fauchereau F, Durand CM, Chevalier F, Drouot X, Collet C, Launay JM, Leboyer M, Gillberg C, Bourgeron T. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 2008, 13(1):90-98. 10.1038/sj.mp.4002016, 2199264, 17505466.
14. Jonsson L, Ljunggren E, Bremer A, Pedersen C, Landen M, Thuresson K, Giacobini M, Melke J. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med Genomics 2010, 3:10. 10.1186/1755-8794-3-10, 3020629, 20377855.
15. Cai G, Edelmann L, Goldsmith JE, Cohen N, Nakamine A, Reichert JG, Hoffman EJ, Zurawiecki DM, Silverman JM, Hollander E, Soorya L, Anagnostou E, Betancur C, Buxbaum JD. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med Genomics 2008, 1:50. 10.1186/1755-8794-1-50, 2588447, 18925931.
16. Pagan C, Goubran-Botros H, Poirier K, Dumaine A, Jamain S, Moreno S, de BA, Van EH, Delorme R, Launay JM, Tzschach A, Kalscheuer VM, Lacombe D, Briault S, Laumonnier F, Raynaud M, van Bon BW, Willemsen MH, Leboyer M, Chelly J, Bourgeron T. Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with Intellectual Disability. BMC Med Genet 2011, 12:17. 3034665, 21251267.
17. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Crespo JM, Gutierrez-Zotes A, Bayes M, Martorell L, Vilella E, Estivill X, Menchon JM, Gratacos M, Urretavizcaya M. Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility. J Pineal Res 2010, 49:35-44.
18. Jang SW, Liu X, Pradoldej S, Tosini G, Chang Q, Iuvone PM, Ye K. N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc Natl Acad Sci USA 2010, 107:3876-3881. 10.1073/pnas.0912531107, 2840510, 20133677.
19. Schomerus C, Korf HW. Mechanisms regulating melatonin synthesis in the mammalian pineal organ. Ann N Y Acad Sci 2005, 1057:372-383. 10.1196/annals.1356.028, 16399907.
20. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study. Am J Hum Genet 2002, 71:651-655. 10.1086/342288, 379201, 12161822.
21. Kremeyer B, Herzberg I, Garcia J, Kerr E, Duque C, Parra V, Vega J, Lopez C, Palacio C, Bedoya G, Ospina J, Ruiz-Linares A. Transmission distortion of BDNF variants to bipolar disorder type I patients from a South American population isolate. Am J Med Genet B Neuropsychiatr Genet 2006, 141:435-439.
22. Nurnberger JI. A simulated genetic structure for bipolar illness. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:952-956. 10.1002/ajmg.b.30724, 18314863.
23. Bremer T, Diamond C, McKinney R, Shehktman T, Barrett TB, Herold C, Kelsoe JR. The pharmacogenetics of lithium response depends upon clinical co-morbidity. Mol Diagn Ther 2007, 11:161-170.
24. Kelsoe J, Leckband S, Demodena A, McKinney R, Shekhtman T. Replication of Association of the NTRK2 gene with Lithium Response in Bipolar Disorder in a Prospective Sample [abstract]. 60th Annual Meeting of The American Society of Human Genetics, November 2, 2010, Washington, D C 2010,
25. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinical rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54:573-583. 10.1016/S0006-3223(02)01866-8, 12946886.
26. Doraiswamy PM, Bernstein IH, Rush AJ, Kyutoku Y, Carmody TJ, Macleod L, Venkatraman S, Burks M, Stegman D, Witte B, Trivedi MH. Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS-C16 and QIDS-SR16) in the elderly. Acta Psychiatr Scand 2010, 122:226-234. 10.1111/j.1600-0447.2009.01531.x, 20085556.
27. Brown FM. Psychometric equivalence of an improved Basic Language Morningness (BALM) Scale using industrial population within comparisons. Ergonomics 1993, 36(1-3):191-197.
28. Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, Lewis C, Cawthon PM, Marcus R, Marshall LM, McGowan J, Phipps K, Sherman S, Stefanick ML, Stone K. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005, 26:569-585. 10.1016/j.cct.2005.05.006, 16084776.
29. Blank JB, Cawthon PM, Carrion-Petersen ML, Harper L, Johnson JP, Mitson E, Delay RR. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 2005, 26:557-568. 10.1016/j.cct.2005.05.005, 16085466.
30. Yesavage JA, Brink TL, Rose TL, Adey M. The geriatric depression rating scale. Comparison with other self-report and psychiatric rating scales. Assessment in Geriatric Psychopharmacology 1983, 153-67. New Haven, Connecticut: Mark Powles Associates, Inc, Crook T, Ferris S, Bartus R.
31. Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, Mascioli SR, Scott JC, Seeley DG, Steiger P. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 1990, 263:665-668. 10.1001/jama.263.5.665, 2404146.
32. Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, O'Donovan C, Teehan A, Alda M. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord 2007, 104:185-190. 10.1016/j.jad.2007.03.003, 17442400.
33. Abecasis G, Li Y. Mach v. 1.0.16. 2010, Ann Arbor, University of Michigan.
34. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
35. Barclay NL, Eley TC, Buysse DJ, Archer SN, Gregory AM. Diurnal preference and sleep quality: same genes? A study of young adult twins. Chronobiol Int 2010, 27:278-296. 10.3109/07420521003663801, 20370470.
36. Baldwin RC, Tomenson B. Depression in later life. A comparison of symptoms and risk factors in early and late onset cases. Br J Psychiatry 1995, 167:649-652. 10.1192/bjp.167.5.649, 8564322.
37. van den Berg MD, Oldehinkel AJ, Bouhuys AL, Brilman EI, Beekman AT, Ormel J. Depression in later life: three etiologically different subgroups. J Affect Disord 2001, 65:19-26. 10.1016/S0165-0327(00)00263-9, 11426505.
38. Sekula LK, Lucke JF, Heist K, Czambel K, Rubin RT. Neuroendocrine aspects of primary endogenous depression XV: mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls. Psychiatry Res 1997, 69:143-153. 10.1016/S0165-1781(96)02937-X, 9109182.
39. Brown GM, Pulido O, Grota LJ, Niles LP. N-Acetylserotonin in the central nervous system. Prog Neuropsychopharmacol Biol Psychiatry 1984, 8:475-480. 10.1016/0278-5846(84)90003-4, 6085173.
40. Hardeland R. Melatonin metabolism in the central nervous system. Curr Neuropharmacol 2010, 8:168-181. 10.2174/157015910792246164, 3001211, 21358968.
41. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, DePaulo JR, Gejman PV, Sanders AR, Johnson JK, Adams P, Chaudhury S, Jancic D, Evgrafov O, Zvinyatskovskiy A, Ertman N, Gladis M, Neimanas K, Goodell M, Hale N, Ney N, Verma R, Mirel D, Holmans P, Levinson DF. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 2011, 16:193-201. 10.1038/mp.2009.124, 20125088.
42. Fan M, Liu B, Jiang T, Jiang X, Zhao H, Zhang J. Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. Psychiatr Genet 2010, 20:1-7. 10.1097/YPG.0b013e3283351112, 20010318.
43. Zhang J, Chen Y, Zhang K, Yang H, Sun Y, Fang Y, Shen Y, Xu Q. A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder. Biol Psychiatry 2010, 68:795-800. 10.1016/j.biopsych.2010.06.004, 20691428.